These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 11319753)

  • 21. Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor.
    Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Inagaki K; Kondo T; Kurita N; Suzuki M; Kanayama N; Terao T
    J Periodontal Res; 2005 Dec; 40(6):461-8. PubMed ID: 16302924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide post-transcriptionally up-regulates LPS-induced IL-8 expression through p38 MAPK activation.
    Ma P; Cui X; Wang S; Zhang J; Nishanian EV; Wang W; Wesley RA; Danner RL
    J Leukoc Biol; 2004 Jul; 76(1):278-87. PubMed ID: 15178710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of p38 MAP kinase activity enhances axonal regeneration.
    Myers RR; Sekiguchi Y; Kikuchi S; Scott B; Medicherla S; Protter A; Campana WM
    Exp Neurol; 2003 Dec; 184(2):606-14. PubMed ID: 14769353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10.
    Tan J; Town T; Saxe M; Paris D; Wu Y; Mullan M
    J Immunol; 1999 Dec; 163(12):6614-21. PubMed ID: 10586056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth factor responsiveness of human articular chondrocytes: distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts.
    Guerne PA; Sublet A; Lotz M
    J Cell Physiol; 1994 Mar; 158(3):476-84. PubMed ID: 8126071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.
    Underwood DC; Osborn RR; Kotzer CJ; Adams JL; Lee JC; Webb EF; Carpenter DC; Bochnowicz S; Thomas HC; Hay DW; Griswold DE
    J Pharmacol Exp Ther; 2000 Apr; 293(1):281-8. PubMed ID: 10734180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
    Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
    J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of IL-1 on mitogen-activated protein kinases in rabbit articular chondrocytes.
    Scherle PA; Pratta MA; Feeser WS; Tancula EJ; Arner EC
    Biochem Biophys Res Commun; 1997 Jan; 230(3):573-7. PubMed ID: 9015364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
    Chopra P; Kulkarni O; Gupta S; Bajpai M; Kanoje V; Banerjee M; Bansal V; Visaga S; Chatterjee M; Chaira T; Shirumalla RK; Verma AK; Dastidar SG; Sharma G; Ray A
    Int Immunopharmacol; 2010 Apr; 10(4):467-73. PubMed ID: 20093202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts.
    Chae HJ; Chae SW; Chin HY; Bang BG; Cho SB; Han KS; Kim SC; Tae KC; Lee KH; Kim DE; Im MK; Lee SJ; Chang JY; Lee YM; Kim HM; Kim HH; Lee ZH; Kim HR
    Bone; 2001 Jan; 28(1):45-53. PubMed ID: 11165942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures.
    Badger AM; Roshak AK; Cook MN; Newman-Tarr TM; Swift BA; Carlson K; Connor JR; Lee JC; Gowen M; Lark MW; Kumar S
    Osteoarthritis Cartilage; 2000 Nov; 8(6):434-43. PubMed ID: 11069728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
    Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
    J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical role for apoptosis signal-regulating kinase 1 in the development of inflammatory K/BxN serum-induced arthritis.
    Mnich SJ; Blanner PM; Hu LG; Shaffer AF; Happa FA; O'Neil S; Ukairo O; Weiss D; Welsh E; Storer C; Mbalaviele G; Ichijo H; Monahan JB; Hardy MM; Eda H
    Int Immunopharmacol; 2010 Oct; 10(10):1170-6. PubMed ID: 20609399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p38 Mitogen-activated protein kinase inhibition reduces inflammatory cytokines in a brain-dead transplant donor animal model.
    Oto T; Calderone A; Li Z; Rosenfeldt FL; Pepe S
    Heart Lung Circ; 2009 Dec; 18(6):393-400. PubMed ID: 19647484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.
    Montalban AG; Boman E; Chang CD; Ceide SC; Dahl R; Dalesandro D; Delaet NG; Erb E; Ernst J; Gibbs A; Kahl J; Kessler L; Lundström J; Miller S; Nakanishi H; Roberts E; Saiah E; Sullivan R; Wang Z; Larson CJ
    Eur J Pharmacol; 2010 Apr; 632(1-3):93-102. PubMed ID: 20132813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones.
    Mårtensson K; Chrysis D; Sävendahl L
    J Bone Miner Res; 2004 Nov; 19(11):1805-12. PubMed ID: 15476580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuropeptide calcitonin gene-related peptide inhibits TNF-alpha but poorly induces IL-6 production by fetal rat osteoblasts.
    Millet I; Vignery A
    Cytokine; 1997 Dec; 9(12):999-1007. PubMed ID: 9417811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes.
    Badger AM; Cook MN; Lark MW; Newman-Tarr TM; Swift BA; Nelson AH; Barone FC; Kumar S
    J Immunol; 1998 Jul; 161(1):467-73. PubMed ID: 9647257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.